As J&J Backs Away From The Altar, Guidant Asks Court For Shotgun Wedding

Johnson & Johnson is likely to point to Guidant's weak third quarter sales and earnings as evidence that recent recalls have had a "material adverse effect" on Guidant

More from Archive

More from Medtech Insight